The treatment of diabetic gastroparesis with botulinum toxin injection of the pylorus.
Lacy
Brian E
BE
Marvin M. Schuster Center for Digestive and Motility Disorders, Johns Hopkins University, School of Medicine, Baltimore, MD, USA. brian.lacy@hitchcock.org
Crowell
Michael D
MD
Schettler-Duncan
Ann
A
Mathis
Carole
C
Pasricha
Pankaj J
PJ
D000328:Adult; D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D003922:Diabetes Mellitus, Type 1 / Q000150:complications* / Q000175:diagnosis; D005260:Female; D005500:Follow-Up Studies; D005746:Gastric Emptying / Q000187:drug effects / Q000502:physiology; D018589:Gastroparesis / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D005773:Gastroscopy; D006801:Humans; D015552:Injections, Intralesional; D008297:Male; D008365:Manometry; D008875:Middle Aged; D011336:Probability; D011708:Pylorus / Q000187:drug effects*; D012016:Reference Values; D018570:Risk Assessment; D012720:Severity of Illness Index; D016037:Single-Blind Method; D016896:Treatment Outcome
D019274:Botulinum Toxins, Type A